COVID-19 Researchers

Medicine & Life Sciences

1. Infections 100%
2. Coronavirus 82%
3. Alzheimer Disease 76%
4. HIV 72%
5. Therapeutics 63%
6. Genes 63%
7. SARS Virus 62%
8. T-Lymphocytes 62%
9. Lung 61%
10. Viruses 60%
11. Antibodies 57%
12. West Nile virus 55%
13. Pediatrics 50%
14. Sepsis 49%
15. Mortality 48%
16. Severe Acute Respiratory Syndrome 48%
17. Proteins 45%
18. Virus Diseases 45%
19. Wounds and Injuries 45%
20. Heart Failure 42%
21. Vaccines 42%
22. Child 41%
23. Filarial Elephantiasis 41%
24. Lung Transplantation 40%
25. Anti-Bacterial Agents 40%
26. Confidence Intervals 40%
27. Parkinson Disease 39%
28. Mutation 38%
29. Population 38%
30. Immunity 38%
31. Depression 38%
32. Dendritic Cells 38%
33. West Nile Fever 36%
34. Brain 35%
35. Pandemics 35%
36. Transplants 35%
37. Randomized Controlled Trials 35%
38. Antiviral Agents 34%
39. Macrophages 33%
40. Interferons 33%
41. Inflammation 31%
42. Antigens 31%
43. Survival 30%
44. Cohort Studies 30%
45. Hospital Emergency Service 29%
46. Biomarkers 29%
47. Cytokines 28%
48. Monoclonal Antibodies 28%
49. Phenotype 27%
50. Odds Ratio 27%
51. Monocytes 27%
52. Allografts 27%
53. Intensive Care Units 27%
54. Messenger RNA 27%
55. Kidney 26%
56. Transplant Recipients 26%
57. Elderly 26%
58. Dengue Virus 26%
59. Epitopes 26%
60. Genome 26%
61. B-Lymphocytes 25%
62. Zika Virus 25%
63. Vaccination 25%
64. Amyloid 25%
65. Epidemiology 24%
66. Cerebrospinal Fluid 24%
67. Vesicular Stomatitis 24%
68. Delivery of Health Care 24%
69. Gene Expression 23%
70. Transcription Factors 23%
71. Neoplasms 23%
72. Occupational Groups 23%
73. Communicable Diseases 22%
74. Antimicrobial Stewardship 22%
75. Mass Drug Administration 22%
76. Flavivirus 22%
77. Asthma 22%
78. Human Influenza 22%
79. RNA 21%
80. Cognitive Dysfunction 21%
81. Systematic Reviews 21%
82. Physicians 21%
83. Incidence 21%
84. Guidelines 21%
85. Clinical Trials 21%
86. Head and Neck Neoplasms 21%
87. Safety 21%
88. Critical Illness 21%
89. Apoptosis 20%
90. Epithelial Cells 20%
91. Lymphocytes 20%
92. Brugia malayi 20%
93. Tuberculosis 20%
94. Neutralizing Antibodies 20%
95. Morbidity 20%
96. Comorbidity 20%
97. Hospitalization 20%
98. Orthomyxoviridae 19%
99. Health 19%
100. Stroke 19%